530125 — Samrat Pharmachem Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for Samrat Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,218	3,106	2,816	2,859	2,897
Cost of Revenue
Gross Profit	319	328	113	191	66.7
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,981	2,874	2,798	2,763	2,926
Operating Profit	237	233	18.2	95.9	-28.6
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	236	225	25.2	98.9	-29.8
Provision for Income Taxes
Net Income After Taxes	172	166	21.6	71.1	-33.1
Net Income Before Extraordinary Items
Net Income	172	166	21.6	71.1	-33.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	172	166	21.6	71.1	-33.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	55.7	53.8	7	23	-10.7
Dividends per Share